Aurobindo Pharma Limited AUROPHARMA

Latest filings

• General25 11 Nov, 20:31 · NSE
  Classification of US FDA Inspection at Lannett Company LLC, a wholly owned subsidiary of Aurobindo Pharma USA, Inc.
• Routine15 11 Nov, 13:09 · BSE
  Submission of Earning Call Transcript for Q2FY27.
• Routine15 11 Nov, 13:05 · NSE
  Transcript
• General25 11 Nov, 11:29 · NSE
  Apitoria Unit 2, an API manufacturing facility of Apitoria Pharma Private Limited., a subsidiary of the Company, receives Establishment Inspection Report from US FDA with classification as Voluntary Action Indicated
• Routine15 9 Nov, 14:48 · NSE
  Schedule of meet
• Routine15 9 Nov, 14:46 · NSE
  Schedule of meet
• Routine15 9 Nov, 14:39 · BSE
  Intimation of investors / analysts meet to be held on 17.11.2026.
• Routine15 9 Nov, 14:34 · BSE
  Intimation of investor / analysts meet to be held on 16.09.2026.
• Routine15 6 Nov, 11:23 · BSE
  Submission of financial results published in newspapers.
• Results73 4 Nov, 20:48 · BSE
  Submission of Financial results for the Quarter and Half year ended September 30, 2026.

Shown 15 minutes after publication. Real time with Pro.